medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2003, Número 4

<< Anterior Siguiente >>

Rev Mex Oftalmol 2003; 77 (4)


Síndrome de pseudoexfoliación y catarata: resultados visuales postoperatorios

Meza-de Regil A, Retchkiman-Bret M, Velasco-Barona C, Cervantes-Coste G

Idioma: Español
Referencias bibliográficas: 65
Paginas: 140-144
Archivo PDF: 424.16 Kb.


RESUMEN

Objetivo: Describir factores y complicaciones que repercuten en la capacidad visual final (CVF) de pacientes con pseudoexfoliación, operados de catarata.
Material y métodos: Estudio retrospectivo, observacional y transversal que incluyó 75 ojos de 69 pacientes con síndrome de pseudoexfoliación, operados de catarata con implante de lente intraocular (LIO). Se determinó, por medio de un análisis multivariado, la presencia de correlación entre factores prequirúrgicos, complicaciones trans y postquirúrgicas y mala CVF.
Resultados: Se encontró una asociación estadísticamente significativa entre mala CVF y los siguientes aspectos: edad (p‹0.024), grado de pseudoexfoliación (p‹0.001), iridodonesis (p‹.031), ruptura de cápsula posterior (p‹0.006), pérdida de vítreo (p‹0.004) y descentración de LIO (p‹0.031). El análisis multivariado encontró asociación entre mala CVF y la edad del paciente (p‹0.010) y el grado de pseudoexfoliación (p‹0.001).
Conclusiones: La iridodonesis, ruptura de cápsula posterior, pérdida de vítreo y descentración influyen en la CVF de dichos pacientes; sin embargo, la edad y el grado de pseudoexfoliación fueron los factores de mayor repercusión en la mala CVF obtenida. El tipo de cirugía y la experiencia del cirujano no influyeron en el resultado visual final.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ringvold A: On the occurrence of pseudoexfoliation material in extrabulbar tissue from patients with pseudoexfoliation syndrome of the eye. Acta Ophthalmol (Copen) 1973;51:511-518.

  2. Schlötzer-Schrehardt UM, Kuchle M, Naumann GO: Electronmicroscopic identification of pseudoexfoliation material in extra bulbar tissue. Arch Ophthalmol 1991;109:565-570.

  3. Streeten BW: Pseudoexfoliative fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthalmol 1990;110:490-499.

  4. Sugino T: [Exfoliative materials in the skin of patients with exfoliation syndrome]. Nipón Ganka Gakki Zasshi 1990;94:856-869.

  5. Schlotzer-Schrehardt UM, Koca MR, Naumann GO: Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder. Arch Ophthalmol 1992; 110:1752-1756.

  6. Streeten BW, Li YZ, Wallace RN: Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992; 110:1757-1762.

  7. Lindberg JG: [Clinical studies of depigmentation of the papillary margin and transillumination of the iris in cases of senile cataract and also in the normal eyes of the aged]. Thesis. Helsingfors, 1917.

  8. Lindberg JG: Clinical investigations on depigmentation of the pupilary border and translucency of the iris in cases of senile cataract and in normal eyes in the elderly persons. Acta Ophthalmol (Suppl) 1989;190:1-96.

  9. Forsius H: Exfoliation syndrome in various ethnic populations. Acta Ophthalmol (Suppl) 1988;184:71-85.

  10. Pohjanpelto PEJ, Hurskainen L: Studies on relatives of patients with glaucoma simplex and patients with pseudoexfoliation of the lens capsule. Acta Ophthalmol (Copen) 1972; 50:255-261.

  11. Tarkkanen A, Voipio G, Krivusalo P: Family study of pseudoexfoliation and glaucoma. Acta Ophthalmol 1993; 43:683-697.

  12. Ritch R: Exfoliation syndrome: The most common identifiable cause of open-angle glaucoma. J Glaucoma 1994; 3:176-178.

  13. Naumann GO, Schlotzer-Schrehardt UM, Küchle M: Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 1998;105: 951-968.

  14. Alfaiate M, Leite E, Mira J, y col: Prevalence and surgical complications of pseudoexfoliation syndrome in Portuguese patients with senile cataract. J Cataract Refract Surg 1996; 22:972-976.

  15. Avramides S, Traianidis P, Sakkias G: Cataract surgery and lens implantation in eyes with pseudoexfoliation syndrome. J Cataract Refract Surg 1997;23:583-587.

  16. Awan KJ, Humayun M: Extracapsular cataract surgery risks in patients with exfoliation syndrome. Pakistan J Ophthalmol 1986; 2:79-80.

  17. Bartholomew RS: Lens displacement associated with pseudocapsular exfoliation. A report on 19 cases in the southern Bantu. Br J Ophthalmol 1970; 54:744-750.

  18. Carpel EF: Pupillary dilation in eyes with pseudoexfoliation syndrome. Am J Ophthalmol 1988; 105:692-694.

  19. Guzek JP, Holm M, Cotter JB: Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology 1987; 94:461-466.

  20. Kirkpatrick JN, Harrad RA: Complicated extracapsular cataract surgery in pseudoexfoliation syndrome: A case report. Br J Ophthalmol 1992; 76:692-693.

  21. Lumme P, Laatikainen L: Exfoliation syndrome and cataract extraction. Am J Ophthalmol 1993; 116:51-55.

  22. Lumme P, Laatikainen L: Risk factors for intraoperative and early postoperative complications in extracapsular cataract surgery. Eur J Ophthalmol 1994; 4:151-158.

  23. Moreno-Montañés J, Duch S, Lajara: Pseudoexfoliationn syndrome: clinical factors related to capsular rupture in cataract surgery. Acta Ophthalmol 1993; 71:181-184.

  24. Naumann GOH, The Erlangen Augenbläter Group: Exfoliation syndrome as a risk factor for vitreous loss in extracapsular cataract surgery. Acta Ophthalmol (Suppl) 1988; 184:129-131.

  25. Ota I, Miyake S, Miyake K: Dislocation of the lens nucleus into the vitreous cavity after standard hydro dissection. Am J Ophthalmol 1996; 121:706-708.

  26. Perasalo R, Tarkkanen A: Posterior chamber lens implantation in capsular glaucoma. Acta Ophthalmol (Suppl) 1987; 182:24-26.

  27. Raita C, Setala K: Intraocular lens implantation in exfoliation syndrome and capsular glaucoma. Acta Ophthalmol (Copen) 1986; 64:130-133.

  28. Skuta GL, Parrish RK, Hodapp E: Zonular dialysis during extracapsular cataract extraction in pseudoexfoliation syndrome. Arch Ophthalmol 1987; 105:632-634.

  29. Davison JA: Capsular contraction syndrome. J Cataract Refract Surg. 1993; 19:582-589.

  30. Gallagher SP, Pavilack MA: Risk factors for anterior capsule contraction syndrome with polypropylene or PMMA haptics. J Cataract Refract Surg. 1999; 25:1356-1361.

  31. Hayashi H, Hayashi K, Nakao F, y col: Anterior capsule contraction and intraocular lens dislocation in eyes with pseudoexfoliation syndrome. Br J Ophthalmol 1998; 82:1429-1432.

  32. Baltatzis S, Georgopoulos G, Theodossiadis P: Fibrin reaction after extracapsular cataract extraction: A statistical evaluation. Eur J Ophthalmol 1993; 3:95-97.

  33. Drolsum L, Hasskjold E, Davanger M: Results and complications after extracapsular cataract extraction in eyes with pseudoexfoliation syndrome. Acta Ophthalmol (Copen) 1993; 71:771-776.

  34. Olivius EOP, Nordell SI, Walinder PE: Fibrinoid reaction after ECCE, and it relationship to exfoliation syndrome. A prospective study. Eur J Implant Ref Surg 1989; 1:5-8.

  35. Walinder PEK, Olivius EOP, Nordell SI: Fibrinoid reaction after extracapsular cataract extraction and relationship to exfoliation syndrome. J Cataract Refract Surg 1989; 15:526-530.

  36. Pojhanpelto P: Long term prognosis of visual field in glaucoma simples and glaucoma capsular. Acta Ophthalmol (Copen) 1985; 63:418-423.

  37. Gillies WE: Pseudoexfoliation of the lens capsule and glaucoma. Aust. J Ophthalmol 1977; 5:18-20.

  38. Cursiefen C, Handel A, Schonherr U, y col: [Pseudoexfoliation syndrome in patients with retinal vein branch and central vein thrombosis]. Klin Monatsbl Augenheilkd 1997; 211:17-21.

  39. Karjalainen K, Tarkkanen A, Merenmies L : Exfoliation syndrome in enucleated hemorrhagic and absolute glaucoma. Acta Ophthalmol (Copen) 1987; 65:320-322.

  40. Kozobolis VP, Detorakis ET, Tsilimbaris MK : Correlation between age-related macular degeneration and pseudoexfoliation syndrome in the population of Crete (Greece). Arch Ophthalmol 1999; 117:664-669.

  41. Mitchell P, Wang JJ, Smith W: Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthaloml 1997; 124:685-687.

  42. Repo LP, Suhonen MT, Terasvirta ME, y col: Color doppler imaging of the ophthalmic artery blood spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome. Ophthalmology 1995; 102:1199-1205.

  43. Savage JA, Thomas JV, Belcher CD, y col : Extracapsular cataract extraction and posterior chamber intraocular lens implantation in glaucomatous eyes. Ophthalmology 1985; 92:1506-1516.

  44. DarK AJ, Streeten BW : Precapsular film on the aging human lens: precursor of pseudoexfoliation? Br J Ophthalmol 1990; 74:717-722.

  45. Tetsumoto K, Schlötzer-Schrehardt U, Koskenvuo M: Precapsular layer of the anterior lens capsule in early pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 1992; 230:252-257.

  46. Mardin CY, Schlötzer-Schrehardt U, Naumann GO: [Early diagnosis of pseudoexfoliation syndrome. A clinical electron microscopy correlation of the central, anterior lens capsule]. Klin Monatsbl Augenheilkd 1997; 211:296-300.

  47. Drolsum L: The influence of age on characteristics of cataract patients. Acta Ophthalmol (Copen) 1994; 72(5):622-626.

  48. Scorolli L, y col : Pseudoexfoliation syndrome: a cohort study on intraoperative complications in cataract surgery. Ophthalmologica 1998; 212(4):278-280.

  49. Drolsum L : Pseudoexfoliation syndrome and extracapsular cataract extraction. Acta Ophthalmol (Copen) 1993; 71(6):765-770.

  50. Drolsum L: Phacoemulsification in eyes with pseudoexfoliation. J Cataract Refract Surg.1998;24(6):787-92.

  51. Fine IH, Hoffman RS: Phacoemulsification in the presence of pseudoexfoliation: challenges and options. J Cataract Refract Surg 1997; 23:160-165.

  52. van Heyningen V: Developmental eye disease, a genome era paradigm. Clin Genet 1998; 54:272-282.

  53. O’Rahily R: The timing and sequence of events in the development of the human endocrine system during the embryonic period proper. Anat Embry 1983; 166:439-451.

  54. Allingam RR: Glaucoma. En: Albert DM, Jakobiec FA (eds). Principles and practice of ophthalmology: Clinical practice. Vol 3, Philadelphia, WB Saunders, p. 1291.

  55. Francois J: Congenital glaucoma and its inheritance. Ophthalmologica 1980; 181:61-73.

  56. deLuise VP, Anderson DR: Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol 1983; 28:1-19.

  57. Fox RR, Crary DD, Babibo EJ Jr, Sheppard LB: Buphthalmia in the rabbit. Pleiotropic effects of the (bu) gene and a possible explanation of mode of gene action. J Hered 1969; 60:206-212.

  58. Sarfarazi M, Akarsu AN, Hossain A, y col.: Assignment of a locus (GLC3A) for primary congenital glaucoma (buphthalmos) to 2p21and evidence for genetic heterogeneity. Genomics 1995; 30:171-177.

  59. Akarsu AN, Turacli ME, Aktan GS, y col. A second locus (GLC3B) for primary congenital glaucoma (buphthalmos) maps to the 1p36 region. Hum Mol Genet 1996; 5:1199-1203.

  60. Stoilov J, Akarsu AN, Sarfarazi M: Identification of three different truncating mutations in the cytochrome P4501B1 (CYP1B1) gene as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997; 6:641-647.

  61. Tang YM, Wo YYP, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF: Isolation and characterization of the human cytochrome P450 gene. J Biol Chem 1996; 271: 28324-28330.

  62. Cuevas-Covarrubias SA, Jiménez-Vaca AL, González-Huerta LM, Valdes-Flores M, Rivera-Vega MR, Maya-Nunez G, Kofman-Alfaro S: Somatic and germinal mosaicism for the steroid sulfatase gene deletion in a steroid sulfatase deficiency carrier. J Invest Dermatol 2002; 119:972-975.

  63. Hanna IH, Dawling S, Roodi N, Guengeruch FP, Parl FF: Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000; 60:3440-3444.

  64. Stoilov I, Nurten A, Alozie I, Child A, Barsoum-Homsy M, Erol M, Or M, Lewis RA, Ozdemir N, Brice G, Gulderen S, Chevrette L, Coca-Prados M, Sarfarazi M: Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome p450B1. Am J Hum Genet 1998; 62:573-574.

  65. Beijjani BA, Lewis RA, Tomey KF, Anderson KL, Dueker DK, Jabak M, Astle WF, Otterud B, Leppert M, Lupski JR: Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 1998; 62:325-333.




2020     |     www.medigraphic.com